| 1 |
34427052 | A 24-month metformin treatment study of children with obesity: Changes in circulating GDF-15 and associations with changes in body weight and visceral fat. | 2022 Feb |
4 |
| 2 |
34779127 | Metformin induces insulin secretion by preserving pancreatic aquaporin 7 expression in type 2 diabetes mellitus. | 2022 Feb |
2 |
| 3 |
34849709 | GDF15 in Appetite and Exercise: Essential Player or Coincidental Bystander? | 2022 Jan 1 |
1 |
| 4 |
33686698 | Genetically proxied growth-differentiation factor 15 levels and body mass index. | 2021 Oct |
1 |
| 5 |
33807522 | Multifaceted Mechanisms of Action of Metformin Which Have Been Unraveled One after Another in the Long History. | 2021 Mar 5 |
2 |
| 6 |
34381196 | GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease. | 2021 Oct |
3 |
| 7 |
34790753 | Metformin alleviates bevacizumab-induced vascular endothelial injury by up-regulating GDF15 and activating the PI3K/AKT/FOXO/PPARγ signaling pathway. | 2021 Oct |
3 |
| 8 |
31875646 | GDF15 mediates the effects of metformin on body weight and energy balance. | 2020 Feb |
1 |
| 9 |
32051582 | Publisher Correction: GDF15 mediates the effects of metformin on body weight and energy balance. | 2020 Feb |
1 |
| 10 |
32310257 | GDF15: A Hormone Conveying Somatic Distress to the Brain. | 2020 Aug 1 |
2 |
| 11 |
32427048 | Noncoding SNPs associated with increased GDF15 levels located in a metformin-activated enhancer region upstream of GDF15. | 2020 Jun |
3 |
| 12 |
33312159 | GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin. | 2020 |
5 |
| 13 |
30178545 | Metformin is the key factor in elevated plasma growth differentiation factor-15 levels in type 2 diabetes: A nested, case-control study. | 2019 Feb |
7 |
| 14 |
31161347 | The impact of GDF-15, a biomarker for metformin, on the risk of coronary artery disease, breast and colorectal cancer, and type 2 diabetes and metabolic traits: a Mendelian randomisation study. | 2019 Sep |
5 |
| 15 |
31705902 | Pharmacology of metformin - An update. | 2019 Dec 15 |
1 |
| 16 |
32694673 | Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss. | 2019 Dec |
3 |
| 17 |
30146065 | Treatment-damaged hepatocellular carcinoma promotes activities of hepatic stellate cells and fibrosis through GDF15. | 2018 Sep 15 |
3 |
| 18 |
27974345 | Growth Differentiation Factor 15 as a Novel Biomarker for Metformin. | 2017 Feb |
8 |
| 19 |
28975647 | Effect of metformin and celecoxib on cytotoxicity and release of GDF-15 from human mesenchymal stem cells in high glucose condition. | 2017 Oct |
3 |
| 20 |
23395946 | Metformin induces a senescence-associated gene signature in breast cancer cells. | 2013 Feb |
1 |